Early research (Phase 1)Not Yet RecruitingNCT07523282
What this trial is testing
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
Who this might be right for
Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Sclerosis (SSc)
Shenzhen MagicRNA Biotechnology Co., Ltd 12